The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
Pune (Maharashtra) [India], October 20 (ANI): Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said that the medical firm stopped the production of the Covishield vaccine since December 2021.
New Delhi [India], August 30 (ANI): With a mere 12 per cent coverage of precaution doses across the country so far, the Union Health Ministry has raised concerns over the low inoculation among eligible beneficiaries, said sources on Tuesday.
New Delhi [India], August 30 (ANI): The usage of Covishield has been the highest as the precaution dose for COVID-19 as compared to other vaccines, said Union Health Ministry sources on Tuesday.
New Delhi [India], August 10 (ANI): Union Health Secretary Rajesh Bhushan on Wednesday said that the Centre has approved Biological E's Corbevax as a precaution dose after completion of six months from the date of administration of the second dose of either Covaxin or Covishield vaccines
New Delhi [India], August 10 (ANI): The Central government has approved Biological E's Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday.
Hyderabad (Telangana) [India], August 9 (ANI): Finance, Health, Medical and Family Welfare Minister of Telangana, Thanneeru Harish Rao wrote to Union Health and Family Welfare minister Manusukh Mandaviya requesting him to supply 50 lakhs doses of Covishield vaccine urgently to the state.
Hyderabad (Telangana) [India], July 15 (ANI): Amid the ongoing 75 days COVID-19 booster dose drive, Urban Primary Health Centre's Medical in-charge of Gaganmahal, Hyderabad, Dr Raja Lakshmi said that the centres are having sufficient amount of stock of both Covishield and Covaxin.
New Delhi [India], July 11 (ANI): The National Technical Advisory Group on Immunisation (NTAGI's) Covid working group is expected to conduct a meeting soon to discuss India's first mRNA vaccine against COVID and Biological E's Corbevax Booster dose for Covishield and Covaxin beneficiaries